61 records, the earliest from 14 Jul 2011. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
61 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 10 Aug 2026 | Financial Results | To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 |
| 18 May 2026 | Financial Results | To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026 |
| 9 Feb 2026 | Financial Results | To consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 31, 2025 |
| 14 Jan 2026 | Fund Raising | To consider Fund Raising through Preferential Allotment |
| 10 Nov 2025 | Financial Results | Sun Pharma Advanced Research Company Limited has informed the exchange about Board Meeting to be held on 10-Nov-2025 to inter-alia consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2025 |
| 4 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 19 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
| 10 Feb 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
| 4 Nov 2024 | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| 5 Aug 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
